PRESS RELEASE published on 01/11/2024 at 18:00, 2 years 2 months ago BioGX Expands PCR Test Menu at State Departments of Health BioGX, a leading provider of molecular diagnostic solutions, has announced the expansion of its test menu to support state Departments of Health with the addition of its Candida auris assay. This expansion will provide access to BioGX's molecular assays designed for speed, precision, and reliability, empowering healthcare professionals with the best tools available to improve public health outcomes. Healthcare Professionals BioGX Molecular Diagnostic Solutions Candida Auris Assay Public Health
PRESS RELEASE published on 07/24/2023 at 06:00, 2 years 8 months ago BioGX Candida Auris PCR Assay Global Adoption Accelerates
PRESS RELEASE published on 03/23/2023 at 19:00, 3 years ago BioGX Candida Auris PCR Assay Adoption Accelerates
PRESS RELEASE published on 02/28/2023 at 21:00, 3 years 1 month ago BioGX Ships First Batch of pixl(TM) Real-Time PCR Platform to US Laboratories
Published on 04/08/2026 at 02:50, 3 hours 29 minutes ago Panther Minerals Announces Appointment of Rick Mah to Board of Directors
Published on 04/08/2026 at 01:35, 4 hours 44 minutes ago Polaris Renewable Energy Announces Q1 2026 Investor Call Details
Published on 04/08/2026 at 00:40, 5 hours 39 minutes ago Relevant Gold Announces Initial Closing of Strategic Financing
Published on 04/08/2026 at 00:10, 6 hours 9 minutes ago Trans Canada Gold Completes the Acquisition of the Harrison Lake District Scale Gold Property and First Tranche of the Non-Brokered Private Placement
Published on 04/08/2026 at 00:00, 6 hours 19 minutes ago Onco-Innovations Executes Engagement Agreement with RDI Partners and Establishes Onco-Innovations AU Pty. Ltd. to Advance Australian Phase I Strategy
Published on 04/08/2026 at 01:30, 4 hours 48 minutes ago DFC Funding Positions PELA to Deliver Critical Antimony Supply to U.S. and Allied Markets
Published on 04/07/2026 at 16:32, 13 hours 46 minutes ago Andera Partners portfolio company, Tubulis, acquired by Gilead, adding a potentially best-in-class antibody-drug conjugate and a next-generation platform to Gilead’s oncology pipeline.
Published on 04/07/2026 at 16:30, 13 hours 49 minutes ago From Old Channel to New Garden: How Chaoyang’s 'Sakura River' is Dazzling Spring
Published on 04/07/2026 at 15:00, 15 hours 19 minutes ago Amrize Announces Date for First Quarter 2026 Financial Results
Published on 04/07/2026 at 17:57, 12 hours 21 minutes ago Peugeot Invest publishes its 2025 Universal Registration Document
Published on 04/07/2026 at 17:45, 12 hours 34 minutes ago ENGIE accelerates the deployment of battery storage with nearly 400 MW of new projects in Europe
Published on 04/07/2026 at 17:38, 12 hours 40 minutes ago Reporting on share buyback transactions carried out between March 30 and April 2, 2026
Published on 04/07/2026 at 17:35, 12 hours 44 minutes ago Disclosure of the number of shares and the total number of voting rights as of March 31, 2026
